PowerVision Inc.’s FluidVision, an intraocular lens designed to treat presbyopia and/or cataracts, is the only technology that restores true accommodation, reported company President and CEO Barry Cheskin at the OIS forum. It does so by efficiently harnessing the natural muscular forces of accommodation in the eye to move fluids inside the lens. That fluid movement causes a shape change, which leads to a large change in the power of the intraocular lens. The lens is delivered with the pre-loaded PowerJect IOL injector system. PowerVision plans to begin its FDA trial sometime in 2015.



Barry Cheskin

Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin has over 20 years of general management experience in the medical device business.

View Full Profile